The prognostic value of the immune cell infiltrate in the breast carcinoma microenvironment is still uncertain. We reviewed published articles analysing the infiltration of inflammatorycells in the microenvironment of breast carcinoma. Data revealed the importance of infiltration of these immune cells in the prognosis of breast carcinoma, particularly the triple-negative and HER2-positive phenotypes. Tumour-infiltrating lymphocytes and their subtypes play a fundamental role in predicting the pathological complete response (pCR) to neoadjuvant chemotherapy. More research aiming to dissect a complex network of communication between cancer cells and other cellular components of the tumour microenvironment is necessary to develop more effective...
Immune response which involves distinct immune cells is associated with prognosis of breast cancer. ...
Background: Pre-treatment tumour-associated lymphocytes (TILs) and stromal lymphocytes (SLs) are ind...
Background: Pre-treatment tumour-associated lymphocytes (TILs) and stromal lymphocytes (SLs) are ind...
The prognostic value of the immune cell infiltrate in the breast carcinoma microenvironment is still...
Recently, immune edition has been recognized as a new hallmark of cancer. In this respect, some clin...
While breast cancer has not been considered a cancer amenable to immunotherapeutic approaches, recen...
Not all breast cancer patients benefit from neoadjuvant or adjuvant therapy, resulting in considerab...
Introduction: The antitumor host immune response is an important factor in breast cancer, but its ro...
In recent years, results obtained from different studies with large cohorts have revealed a bond bet...
Risk of metastasis formation is provided by both tumor cell biological characteristics and the micro...
Immune infiltration of breast tumours is associated with clinical outcome. However, past work has no...
Recently, immune edition has been recognized as a new hallmark of cancer. In this respect, some clin...
Background: Not all breast cancer patients benefit from neoadjuvant or adjuvant therapy, resulting i...
With a high risk of relapse and death, and a poor or absent response to therapeutics, the triple-neg...
Background: Not all breast cancer patients benefit from neoadjuvant or adjuvant therapy, resulting i...
Immune response which involves distinct immune cells is associated with prognosis of breast cancer. ...
Background: Pre-treatment tumour-associated lymphocytes (TILs) and stromal lymphocytes (SLs) are ind...
Background: Pre-treatment tumour-associated lymphocytes (TILs) and stromal lymphocytes (SLs) are ind...
The prognostic value of the immune cell infiltrate in the breast carcinoma microenvironment is still...
Recently, immune edition has been recognized as a new hallmark of cancer. In this respect, some clin...
While breast cancer has not been considered a cancer amenable to immunotherapeutic approaches, recen...
Not all breast cancer patients benefit from neoadjuvant or adjuvant therapy, resulting in considerab...
Introduction: The antitumor host immune response is an important factor in breast cancer, but its ro...
In recent years, results obtained from different studies with large cohorts have revealed a bond bet...
Risk of metastasis formation is provided by both tumor cell biological characteristics and the micro...
Immune infiltration of breast tumours is associated with clinical outcome. However, past work has no...
Recently, immune edition has been recognized as a new hallmark of cancer. In this respect, some clin...
Background: Not all breast cancer patients benefit from neoadjuvant or adjuvant therapy, resulting i...
With a high risk of relapse and death, and a poor or absent response to therapeutics, the triple-neg...
Background: Not all breast cancer patients benefit from neoadjuvant or adjuvant therapy, resulting i...
Immune response which involves distinct immune cells is associated with prognosis of breast cancer. ...
Background: Pre-treatment tumour-associated lymphocytes (TILs) and stromal lymphocytes (SLs) are ind...
Background: Pre-treatment tumour-associated lymphocytes (TILs) and stromal lymphocytes (SLs) are ind...